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L
antibiotics are (methyl)lanthionine-containing antimicrobial
peptides produced by a range of bacteria.
1 Nisin A is a 34-
amino-acid polycyclic peptide produced by Lactococcus lactis
sbsp. lactis ATCC 11454 (Figure 1A). It has emerged as the
prototype for studying the antibacterial properties and structure 
activity relationships of the lantibiotics.
2,3 Nisin is ribosomally
synthesized as a linear precursor peptide and then post-transla-
tionally modiﬁed, generating two dehydroalanines, one dehy-
drobutyrine, and ﬁve (methyl)lanthionine cross-links.
1,3
Nisin acts upon Gram-positive bacteria by two distinct
mechanisms.
2 The compound forms pores in cell membranes
4
and inhibits cell wall biosynthesis by disruption of transglycosy-
lation via binding to and mislocalization of lipid II.
5,6 Lipid II
(Figure 1B)isanessentialintermediateforcellwallbiosynthesis.
With twomechanismsofaction, nisin hasbeenrelativelyunaﬀected
bytheemergenceofmicrobialresistance,despitewidespreadand
persistent use as a food preservative.
3,7
Nisin also inhibits the outgrowth of germinated bacterial
spores.
8 12 Organisms from several families of bacteria, includ-
ing the Bacillacaea, form small endospores in nutrient-deprived
conditions, allowing survival over extended periods of time,
whichwouldnotbepossibleasvegetativecells.
13 15Theendospore
structure provides protection in a wide range of environments
including protection against oxidation, radiation, desiccation,
heat, and extremes in pH.
16 The endospore consists of a dual
membrane separated by a thick peptidoglycan cortex and two
proteinaceous layers, the inner and outer spore coats, all sur-
rounding an inner core containing the DNA (Figure 1C).
13 15
Upon encountering more favorable conditions, dormant spores
germinate and undergo sequential developmental changes re-
sulting in outgrowth to vegetative cells.
13 15 For pathogenic
spore-forming bacteria, inhibition of spore outgrowth immedi-
ately after germination initiation is an ideal time for antibiotic
intervention, because the spore has lost its dormancy and pro-
tectivepropertiesbuthasnotyetstartedtoproducethevirulence
factors that contribute to subversion of the host’s immune
response and the progression of disease.
14 19
A recent study with Bacillus anthracis suggested that mem-
brane disruption by nisin prevents the establishment of a mem-
branepotentialandoxidativemetabolismtoinhibitoutgrowthof
germinated spores.
9 Whether these processes are mediated by
lipid II was not established, nor could inhibition of cell wall
biosynthesis be ruled out as a mode of action. At present, little is
known regarding lipid II content and accessibility on spores.
Moreover, several studies have suggested that covalent binding
to a protein target mediates nisin’s inhibitory action on spore
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ABSTRACT: The lantibiotic nisin inhibits growth of vegetative Gram-positive bacteria
bybindingtolipidII,whichdisruptscellwallbiosynthesisandfacilitatesporeformation.
Nisin also inhibits the outgrowth of bacterial spores, including spores of Bacillus
anthracis, whose structural and biochemical properties are fundamentally diﬀerent from
those of vegetative bacteria. The molecular basis of nisin inhibition of spore outgrowth
hadnotbeenidentiﬁed,aspreviousstudiessuggestedthatinhibitionofspore outgrowth
involved either covalent binding to a spore target or loss of membrane integrity;
disruption of cell wall biosynthesis via binding to lipid II had not been investigated. To
provide insights into the latter possibility, the eﬀects of nisin were compared with those
ofvancomycin,anotherlipidIIbindingantibioticthatinhibitscellwallbiosynthesisbutdoesnotformpores.Nisinandvancomycin
both inhibited the replication of vegetative cells, but only nisin inhibited the transition from a germinated spore to a vegetative cell.
Moreover,vancomycinpreventednisin’sactivityincompetitionstudies,suggestingthatthenisin-lipidIIinteractionisimportantfor
inhibition of spore outgrowth. In experiments with ﬂuorescently labeled nisin, no evidence was found for a covalent mechanism for
inhibitionofspore outgrowth.Interestingly, mutants inthehingeregion(N20P/M21P andM21P/K22P)thatstillbindlipidIIbut
cannot form pores had potent antimicrobial activity against vegetative B. anthracis cells but did not inhibit spore outgrowth.
Therefore, pore formation is essential for the latter activity but not the former. Collectively, these studies suggest that nisin utilizes
lipid II as the germinated spore target during outgrowth inhibition and that nisin-mediated membrane disruption is essential to
inhibit spore development into vegetative cells.745 dx.doi.org/10.1021/cb1004178 |ACS Chem. Biol. 2011, 6, 744–752
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outgrowth.
8,10,20 To better understand the mechanism of inhibi-
tion of spore outgrowth, the eﬀects of nisin, vancomycin, and
nisin analogues (Figure 1A,D) on germination and outgrowth of
B.anthracisSterne 7702spores were compared;vancomycinand
the nisin analogues bind to lipid II but do not form pores. These
studies show that nisin does bind lipid II on spores but that lipid
II binding is not suﬃcient for outgrowth inhibition, whereas
membrane disruption is essential. In contrast, lipid II binding is
suﬃcientforantimicrobialactivityagainstvegetativecells.
6Using
ﬂuorescentlylabelednisinanalogues,noevidencewasfoundfora
covalent mechanism of inhibition.
’METHODS
Spore Preparations. Spores were prepared from B. anthracis
Sterne 7702 or B. anthracis 34F2, as described previously.
21 Both strains
do not contain the plasmid pX02 that encodes the genes for capsule
production. Enumeration of spores was performed using a Petroff-
Hauser hemocytometer under a light microscope at 400x magnification
(Nikon Alphaphot YS). A typical spore preparation yielded 10 mL of
spores at a concentration of 2.0   10
9 spores/mL.
Labeling of Nisin and Vancomycin. Nisin was purified and
characterized as described previously.
9 Nisin was reacted with NHS-
fluorescein (Pierce) or with NHS-BODIPY-633 (Invitrogen) to gen-
erate analogues with a single fluorescein group (f-nisin) or a single
BODIPY group (b-nisin) after purification. The reactions were carried
outaccordingtothemanufacturer’sprotocolsexceptthata0.75:1molar
ratio of NHS-fluorophore and nisin was used. Labeling reactions were
stopped with the addition of 100-fold molar excess of Tris after a 3 h
reaction time at 25 C. Reactions were analyzed via matrix assisted laser
desorption ionization-time-of-flight (MALDI-TOF) and electrospray
ionization (ESI) mass spectrometry (MS) (Applied Biosystems), which
indicated that all nisin was consumed. Proteolytic digest of the fluores-
cently labeled compounds with trypsin and chymotrypsin and subse-
quent analysis by LC MS showed that the label was located
predominantly (>85%) at the N-terminus of b-nisin and at the C-term-
inal Lys of f-nisin. Vancomycin was labeled with NHS-rhodamine
(Pierce) to obtain r-vancomycin, with NHS-fluorescein to generate
f-vancomycin, or with NHS-BODIPY-633 to produce b-vancomycin as
previously described.
22Vancomycinlabelingoccursontheaminogroup
of the vancosamine sugar (Figure 1D).
22 All labeled compounds were
purifiedbyreversephase-highperformanceliquidchromatography(RP-
HPLC) utilizing a C4 semipreparative column (Waters) with a linear
gradient of 0 100% acetonitrile with 0.1% trifluoroacetic acid over
40 min. Acetonitrile, TFA, and water were removed from fractions
containing nisin or vancomycin by rotary evaporation followed by
lyophilization. Prior to use, lyophilized nisin and vancomycin were
dissolved in 0.1 M MOPS pH 6.8 to yield the desired concentration.
Truncation of Nisin with Chymotrypsin. Proteolysis of nisin
with chymotrypsin was performed as previously described.
23 Reactions
were analyzed by MALDI-TOF MS. The N-terminal chymotryptic
segment (c-nisin, Figure 1A) was purified from full length nisin and
the C-terminal fragment by RP-HPLC utilizing a C4 semipreparative
column (Waters) with a linear gradient of 0 100% acetonitrile over
40 min. Acetonitrile, TFA, and water were removed from fractions
containing c-nisin by rotary evaporation followed by lyophilization.
Culturing B. anthracis Spores. B. anthracis 34F2 mutants were
graciously provided by Dr. David Popham (Virginia Tech). B. anthracis
Sterne 7702, B. anthracis 34F2, B. anthracis 34F2 ΔsleB,
24 B. anthracis
34F2 ΔcwlJ1,
24 or B. anthracis 34F2 ΔsleBΔcwlJ1
25 spores at a
concentration of 4.0   10
6 spores/mL were incubated in brain heart
infusion medium (BHI; BD Bioscience) supplemented with nisin (at 1
or 10 μM), c-nisin (10 μM), nisin variants (S5A, N20P/M21P, or
M21P/K22P at 10 μM), vancomycin (at 0.1, 1, 10, or 100 μM), or with
0.1 M 3-(N-morpholino)propanesulfonic acid (MOPS; Sigma) at pH
6.8 as a control. For nongerminating conditions, 0.1 M MOPS was
substituted for BHI medium. All incubations were performed at 37 C
under aeration at 180 rpm on a rotary shaker and under ambient CO2.
Differential Interference Contrast (DIC) and Epi-fluores-
cence Microscopy. Live epi-fluorescence microscopy was performed
by mounting samples on glass slides in 0.5% agarose under coverslips.
Figure 1. Structures of nisin, vancomycin, and lipid II. (A) The
structure of nisin A. Dehydroalanine (Dha) and dehydrobutyrine
(Dhb) are indicated in green and magenta, respectively. Lanthionine
and methyllanthionine cross-links are indicated in red and blue, respec-
tively. The numbers indicate the locations of the amino acids that were
mutated. The N-terminal fragment resulting from chymotrypsin clea-
vage(c-nisin)ishighlightedinmaroon.(B)ThestructureoflipidIIinB.
anthracis. The vancomycin binding site is indicated in red, and the nisin
binding site is indicated in blue. m-DAP: diaminopimelic acid. (C)
Transmission electron microscopy image of a B. anthracis Sterne 7702
endospore. (D) The structure of vancomycin.746 dx.doi.org/10.1021/cb1004178 |ACS Chem. Biol. 2011, 6, 744–752
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Images were collected using an Applied Precision assembled DeltaVi-
sion EpiFluorescence microscope containing an Olympus Plan Apo
100x oil objective with NA 1.42 and a working distance of 0.15 mm.
Images were processed and Pearson’s coefficient colocalization analysis
of 50 spores per condition was performed using SoftWoRX Explorer
Suite.Acquisitionofepi-fluorescenceimagesutilizedFITC(Ex:490/20;
Em:528/28),rhodamine(Ex:555/28;Em:617/73),andCy5(Ex:640/
20; Em: 685/40) to visualize fluorescein, rhodamine, and BODIPY-633
fluorescence, respectively.
Functional Competition Assay. Competitive binding of nisin
and vancomycin was evaluated utilizing a functional assay in which
vancomycin prevented nisin-mediated loss of membrane potential via
lipid II binding.
26 Spores were incubated in BHI medium (germinating
conditions), in the presence of 10 mM L-Ala and inosine (germinating
conditions), or in 0.1 M MOPS pH 6.8 (nongerminating conditions)
with 3,30-diethyloxacarbocyanine iodide (DIOC2) for 60 min at 37 C
followed by incubation with 0 or 100 μM vancomycin for 2 min. Nisin
was added to cultures and the effect on membrane potential disruption
was immediately assayed with flow cytometry through 10,000 counts to
observe the population of spores that exhibited reduced membrane
potential in the presence of nisin. The MIC of vancomycin against B.
anthracis is 0.5 3.5 μM,
27 29 but the antimicrobial effects of vancomy-
cin under the conditions used here are not manifested until spores have
been germinated and incubated in the presence of vancomycin for
90min,whichiswellafterthetimeframeofinterestinthisinvestigation.
Experiments investigating spore hydration, oxidative metabolism, mem-
brane potential, and membrane integrity were performed as previously
described.
9 Procedures used for competition binding experiments are
described in the Supporting Information.
Site-Directed Mutagenesis. Mutagenesis of nisA was performed
using the QuikChange mutagenesis kit from Stratagene. Reactions with
complementary mutagenic primers (Supplementary Table S1) were
performed as described in the QuikChange protocol with pRSFDuet-
1nisAB as the plasmid template
30 for the generation of NisA S5A and
M21P mutants. After cycling of the reaction mixture 18 times in a
thermal cycler (MJ Research), the resulting mixture was digested with
DpnI (New England Biolabs), and the resulting DNA was used to
transform supercompetent E. coli DH5R cells. The resulting mutant
plasmidswereisolated,andtheentiregenewassequencedtoensurethat
only the appropriate mutations were introduced. For double mutations,
a second round of site-directed mutagenesis was performed utilizing
pRSFDuet-1nisAB-M21P as the plasmid template for the generation of
NisA N20P/M21P and M21P/K22P mutants.
Heterologous Production of Nisin and Nisin Mutants.
Electro-competent E. coli BL21(DE3) cells were cotransformed with
pRSFDuet-1 containing nisA variants and the nisB gene and pACYC-
Duet-1 containing the nisC gene
30 (Supplementary Table S2). Over-
night culture grown from a single colony transformant was used as
inoculumtogrow2Lofterrificbrothmedium(0.12%PancreaticDigest
of Casein, 0.24% Yeast Extract, BD Biosciences; 0.094% K2HPO4,
0.022% KH2PO4, Fisher Chemical) containing 50 mg/L kanamycin
and 25 mg/L chloramphenicol at 37 C until the OD600 nm reached
about 0.6. The incubation temperature was then changed to 18 C, and
the culture was induced with 0.5 mM IPTG. The induced cells were
shaken continually at 18 C for an additional 18 h. The cells were
harvested by centrifugation (10,000   g for 10 min, Beckman JA-10
rotor).Purificationofthemodifiedprecursorpeptidesisdescribedinthe
Supporting Information.
Cleavage of Modified Prenisin with Trypsin and Purifica-
tion of Nisin Variants. Modified prenisin (500 μM) and trypsin
(30 μM, Worthington Biochemicals) were incubated at RT for 3 h
with 150 rpm mixing on a platform shaker. The resulting mixture was
checked by MALDI-TOF MS, and the desired proteolytic fragment
corresponding to mature nisin or its variants were observed-calculated
for heterologously expressed nisin (h-nisin): 3352.5152 m/z (M þ H),
observed 3352.5005 m/z; calculated for h-nisin S5A: 3354.5608 m/z
(MþH),observed3354.4946m/z;calculatedforh-nisinN20P/M21P:
3301.5673 m/z (M þ H), observed 3301.7642 m/z; and calculated for
h-nisin M21P/K22P 3287.9826 m/z (M þ H), observed: 3287.8738
m/z. Nisin and variants were purified from the cleavage reaction via RP-
HPLC utilizing a C4 semipreparative column with a linear gradient of
0 100% acetonitrile with 0.1% TFA over 40 min. The fractions
containing nisin variants were lyophilized and analyzed by MALDI-
TOF and ESI MS.
’RESULTS AND DISCUSSION
Fluorescently Labeled Nisin Analogues Behave Similarly
toWild-typeNisin.Tofurtherevaluatethemechanismbywhich
nisin inhibits the outgrowth of germinated B. anthracis spores,
bodipy-labeled nisin (b-nisin) and fluorescein-labeled nisin
(f-nisin) were synthesized to probe nisin binding to spores using
fluorescence microscopy. The fluorescein label, which was
located predominantly at the C-terminal lysine residue of nisin,
or the bodipy label, which was located predominantly at the
N-terminus, did not have major deleterious effects on nisin
activity, as fluorescently labeled nisin inhibited B. anthracis
growthwithIC90valuesof5.4and6.5μMforb-nisinandf-nisin,
respectively, which correspond to a 6- and 7-fold loss in activity,
respectively, compared to unmodified nisin.
9 These findings are
consistent with observations in previous reports using nisin
labeled with 5-(aminoacetamido)fluorescein at the C-terminal
carboxylate, which also resulted in an active analogue.
5 Addi-
tional experiments that confirm very similar activities of fluores-
cently labeled nisin analogues and wild-type nisin are presented
in later sections. Importantly, control studies revealed that these
labeled nisin analogues neither induced nor inhibited germina-
tion initiation, as monitored by the loss of optical density
associated with spore hydration during germination (not shown),
analogous to unmodified nisin.
9,10
The binding of b-nisin was compared with a known lipid II
binding probe, ﬂuorescein-vancomycin, (f-vancomycin).
22 Van-
comycin interacts with the D-Ala-D-Ala part of lipid II,
2,31,32
which is distinct from the binding site of nisin that features the
pyrophosphate group (Figure 1B).
33 Fluorescently labeled van-
comycin has been used previously to investigate lipid II localiza-
tion on vegetative bacilli.
22,34 Likenisin,vancomycin (atconcen-
trations up to 100 μM) neither induced nor inhibited spore
germination (Supplementary Figure S1). To verify that ﬂuores-
cently labeled nisin can be used to detect the localization of lipid
II, vegetative B. anthracis cells were incubated with f-nisin or
b-nisin.Previousstudieshavedemonstratedthatnisinrelocalizes
lipid II to patches in bacilli.
5 In our experiments, f-nisin and
b-nisin also localized in patches on B. anthracis (Supplementary
Figure S2). Collectively, these experiments provide support that
the ﬂuorescently labeled nisin analogues bind to lipid II.
Nisin Binds to Lipid II of Germinated Spores. In the
presence of both b-nisin and f-vancomycin (both at 1 μM), the
outgrowth of germinated spores was inhibited, and b-nisin and
f-vancomycin were associated with spores (Figure 2A), although
with distinct binding patterns. Vancomycin was localized diffu-
sely over the entire surface of germinated spores, whereas nisin
waslocalizedinamorepunctatefashionandpredominantlynear
the poles of the germinated spores, where colocalization with
vancomycin was observed (Figure 2A). Co-localization analysis
utilizing Pearson’s coefficient confirmed that vancomycin was747 dx.doi.org/10.1021/cb1004178 |ACS Chem. Biol. 2011, 6, 744–752
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localizedatsites where nisinwas found atalltimepoints (n=50;
Supplementary Figure S3). It is possible that the clustering of
b-nisin near the poles reflects the localization of lipid II that is
required for the biosynthesis of new cell wall during the out-
growth process. However, we cannot rule out that the observed
stronglocalizationatthepolesmaybetheresultofnisin-induced
relocalization of lipid II.
The distinct binding patterns of b-nisin and f-vancomycin
were not caused by intrinsic diﬀerences between bodipy and
ﬂuorescein, because switching the labels (e.g., using ﬂuorescein-
labeled nisin and bodipy-labeled vancomycin) resulted in similar
bindingpatterns(SupplementaryFigureS4A C).Furthermore,
the patterns of nisin and vancomycin binding were independent
of the order in which the compounds were introduced
(Supplementary Figure S5A). Finally, the incubation of spores
with b-nisin under germinating conditions in the absence of
vancomycin also resulted in punctate localization at the pole of
the spore with some diﬀuse ﬂuorescence associated with the
spore membrane (Figure 2B).
Complete colocalization of nisin and vancomycin was not
expected since vancomycin binds the D-Ala-D-Ala structure
present in both the pentapeptide of the non-cross-linked cell
wall and cortex in addition to the pentapeptide of lipid II,
26
whereas nisin will bind to the pyrophosphate that is only present
inlipidII(Figure1B).
33Reﬂectiveofthesediﬀerencesinbinding
speciﬁcities, nisin did not detectably associate with dormant
spores (Supplementary Figure S5B), indicating that lipid II was
not accessible prior to germination initiation. In contrast, vanco-
mycin was associated with dormant spores (Supplementary
Figure S5B), which may be due to the accessibility of non-
cross-linked peptidoglycan within the spore cortex.
Incubationofsporeswithf-vancomycin(1μM)intheabsence
of nisin showed relatively uniform labeling at 30 min, with more
punctuate labeling at 60 min (Figure 2C). Outgrowth of spores
into bacilli altered the localization of vancomycin to bands that
cross the long axis of the bacilli at 120 min (Figure 2C). This
localization of vancomycin in outgrown spores is similar to lipid
II localization observed previously in vegetative bacilli of B.
subtilis and reﬂects the helical localization of lipid II along the
long axis of the rod-shaped cell.
22,34
To provide support that b-nisin binds to lipid II associated
with germinated spores, competition binding experiments were
performed.Thesestudiesrevealedthata100-foldmolarexcessof
unlabeled vancomycinsigniﬁcantly reducedbinding of b-nisinto
the surface of germinated spores (Figure 3A), presumably by
preventing nisin interaction with lipid II as a consequence of
sterichindrance.Likewise,a100-foldmolarexcessofunmodiﬁed
nisin signiﬁcantly inhibited the binding of f-vancomycin to the
surface of spores under germinating conditions (Figure 3B). As
mentioned above, complete competition is not expected since
thesetwocompounds,inadditiontosharinglipidIIastarget,also
havenonoverlapping bindingsites(non-cross-linkedcellwallfor
vancomycin and the membrane for nisin). Importantly, 100-fold
molar excess of unmodiﬁed nisin also signiﬁcantly reduced the
binding of b-nisin to germinated spores (Figure 3C), providing
additional evidence that b-nisin and wild-type nisin bind to the
same target.
Alternative Approaches with Fluorescently Labeled Nisin
Analogues. In an effort to determine whether the time-
dependentlabelingpatternsobservedwithfluorescentlylabelednisin
and vancomycin reflect degradation and processing of the cortex
and cell wall, a series of cortex hydrolase mutants were evaluated
for their ability to alter nisin and vancomycin localization.
Previous studies demonstrated that single knockouts of sleB or
cwlJ1 slowed the rate of cortex hydrolysis while the double
mutant, ΔsleBΔcwlJ1, eliminated cortex hydrolysis in a B.
anthracis 34F2 background.
24,25 In the presence of both b-nisin
and f-vancomycin (both at 1 μM), the outgrowth of germinated
spores of these mutants were inhibited, and b-nisin and f-vanco-
mycinwereassociated withspores (SupplementaryFigure S6A),
with a similar binding pattern observed for the spore variants as
shownaboveforB.anthracis7702(Figure2).Thus,althoughthe
structure of the cell wall is changing during cortex hydrolysis,the
Figure 2. Nisin and vancomycin binding to spores. At time 30, 60, and
120 min, samples were removed and visualized by epi-ﬂuorescence
microscopy. (A) Incubation of germinated spores with 1 μM bodipy-
nisin (b-nisin, red) and ﬂuorescein-vancomycin (f-vancomycin, green).
Co-localization is indicated by yellow in merged images. (B) Incubation
of germinated spores with 1 μM b-nisin (red). (C) Incubation of
germinated spores with 1 μM f-vancomycin (green). For each panel, a
single spore is shown for clarity, but the image is representative of all B.
anthracis spores within that sample.748 dx.doi.org/10.1021/cb1004178 |ACS Chem. Biol. 2011, 6, 744–752
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accessible binding sites for vancomycin and nisin do not appear to
change much. We note that a complementary approach to change
the lipid II content of outgrowing spores by using the lipid II
biosynthesis inhibitors bacitracin and fosfomycin was not possible
because B. anthracis is highly resistant to these compounds.
35 37
Althoughthecollectiveresultsindicatethatnisinbindstolipid
II on the spore surface, the microscopy data do not reveal
whether lipid II is the only nisin target in germinated spores.
Previous studies suggested that nisin may bind covalently to a
protein target during outgrowth inhibition through a Michael-
type addition of a Cys of a spore protein to Dha5 of nisin.
8,10,20
However, extensive eﬀorts to conﬁrm and identify a cognate
protein receptor using ﬂuorescently or biotin-labeled nisin as
probes were unsuccessful (data not shown), consistent with
earlier results emerging frommutagenesis ofDha5.
38 Our results
also argue against a covalent mechanism involving the other
electrophilic sites in nisin.
Lipid II Binding Is Not Sufficient to Inhibit Outgrowth. To
evaluatewhetherlipidIIbindingaloneissufficientfornisin-dependent
outgrowth inhibition, we studied the action of a purified amino-
terminalchymotrypticfragmentofnisin(c-nisin,Figure1A)that
retained the A, B, and C rings of the full-length parent com-
pound. c-Nisin contains the necessary N-terminal portion of
nisinrequired forlipid II binding
33 butis unable toformpores.
38
Competitionassaysbetweenc-nisinandb-nisinrevealedthatthe
bindingofb-nisintogerminatedsporeswassignificantlyreduced
in the presence of 100-fold molar excess of c-nisin (Figure 3C),
once more providing evidence that b-nisin recognizes and
binds lipid II. When incubated with germinated spores, c-nisin
did not demonstrate significant inhibition of spore outgrowth
(Figure 3D, Supplementary Table S4), although a slight delay in
the elongation of vegetative bacilli was observed. These data
indicate that while the chymotrypsin-derived amino terminal
nisin fragment binds lipid II, this fragment alone does not inhibit
the outgrowth of germinated spores. This result is different from
a previous study, which demonstrated that nisin fragments
missing the D and E rings still inhibited B. subtilis spore
outgrowth.
38 Possible explanations for the differentobservations
include differences in spore structure between B. subtilis and
B. anthracis or differences in the methods to determine spore
outgrowth.InthestudyonB.subtilis,outgrowthwasmeasuredby
monitoring optical density at 600 nm, whereas the current work
utilized microscopy to provide direct visual observation
of spore outgrowth. Consistent with the observations that
nonpore forming, lipid II-binding nisin analogues do not inhibit
sporeoutgrowth,vancomycinwasalsoincapableofinhibitingthe
outgrowth of germinated spores (Figure 2). Together, these
results support the model that lipid II binding alone is not
sufficient to inhibit the outgrowth of germinated spores.
Lipid II Binding Is Associated with Loss of Membrane
Potential. Nisin prevents the establishment of a membrane
potential in germinated spores.
9 Although the results presented
here support binding of nisin to lipid II, they do not establish
whether lipid II is important for nisin-dependent membrane
potential dissipation. To evaluate this possibility, the membrane
potential was first measured with germinated spores in the
presence of vancomycin, monitoring the uptake of the cationic
membrane potential dye DiOC2 upon the establishment of a
membrane potential utilizing flow cytometry.
9In these experiments,
vancomycin did not cause much of a decrease in membrane
potential (Figure 4A,B). In contrast, nisin prevented the
establishment of a membrane potential in a large fraction of
the population (Figure 4A C). Furthermore, a significant
decrease of nisin-dependent reduction of the trans-membrane
potential of spores was observed in the presence of a 100-fold
molarexcessofvancomycin(Figure4A).Moreover,germination
of spores in the presence of c-nisin resulted in significantly less
Figure 3. Competition assays with nisin and vancomycin. (A) Compe-
tition assay of spore binding by unlabeled vancomycin and b-nisin. *
indicates a p-value <0.05 between b-nisin-only treated spores (1 μM)
and spores pretreated with unlabeled vancomycin (100 μM) prior to
b-nisin addition. ** indicates a p-value <0.05 between b-nisin-treated
(1μM)sporesandsporestreatedwithunlabeledvancomycin(100μM).
(B) Binding competition assay of unlabeled nisin in competition with
b-vancomycin. * indicates a p-value <0.05 between b-vancomycin
(1 μM) treated spores and spores pretreated with unlabeled nisin
(100 μM) prior to b-vancomycin addition. ** indicates a p-value <0.05
between b-vancomycin (1 μM) treated spores and spores treated with
unlabeled nisin (100 μM). (C) Binding assay of unlabeled c-nisin in
competition with b-nisin. * indicates a p-value <0.05 between b-nisin
(1 μM) treated spores and spores pretreated with unlabeled c-nisin
(100 μM) prior to b-nisin addition. * indicates a p-value <0.05 between
control (0 μM nisin) spores and spores pretreated with unlabeled nisin
orunlabeledc-nisin(100μM)priortob-vancomycinaddition.InA C,
the data are plotted as the mean ﬂuorescent intensity (MFI) associated
with the binding of the labeled antibiotic. (D) At time 0, 5, and 10 h,
samples were removed and visualized by DIC microscopy. For each
panel, a single spore is shown for clarity, but the image is representative
of all other B. anthracis spores within that sample. The data are
representative of those from three independent experiments with 10 μM
nisin or c-nisin.749 dx.doi.org/10.1021/cb1004178 |ACS Chem. Biol. 2011, 6, 744–752
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reduction of spore trans-membrane potential (Figure 4C). Be-
cause these studies were carried out under conditions where
vancomycin or c-nisin reduced the binding of b-nisin to spores
(Figures 3A C), these results suggest that nisin-dependent
reduction of the trans-membrane potential requires binding to
lipid II in newly germinated spores.
Lipid II Binding Is Associated with Nisin-Dependent Al-
terationsinMembraneIntegrity.Nisindisruptsthemembrane
integrity of germinated spores,
9 but the data thus far do not
determinewhethernisin-lipid IIinteractionsarerequired forthis
activity. Therefore, experiments were conducted to examine the
effect on membrane integrity monitored by the uptake of the
membrane-impermeable dye propidium iodide (PI) upon nisin-
induced membrane disruption utilizing flow cytometry.
9 Nisin
induced significantly more PI uptake than c-nisin in over 92% of
the population of spores (Figure 5A,B). Vancomycin was not
able to induce an increase in PI uptake (Figure 5C). In addition,
only nisin was able to render the germinated spore metabolically
inactive prior to outgrowth (Supplementary Figure S8). Collec-
tively,theseresults suggest thatan association between nisin and
lipid II is important for the disruption of membrane integrity.
Figure 4. Lipid II binding is not suﬃcient to inhibit membrane
potential establishment via membrane disruption. (A) Functional
competition assay using nisin-induced dissipation of the membrane
potential as read-out. The data is plotted as the population of spores
exhibitinganativemembranepotentialper10,000sporesasobservedby
ﬂow cytometry using the DiOC2 dye. Preincubation with vancomycin
blocks nisin-mediated membrane potential dissipation. * indicates a
p-value <0.05 between nisin (1 μM) treated spores and spores pre-
treated with vancomycin(100μM)priorto nisinaddition.** indicatesa
p-value <0.05 between nontreated spores and spores treated with
vancomycin (100 μM) only. (B, C) At time 0 (prior to the addition
of 10 μM nisin, c-nisin, or vancomycin) and 30 min aliquots were
removed from the cultures and evaluated for membrane potential by
measuring the DiOC2-associated B. anthracis ﬂuorescence by ﬂow
cytometry. Data are rendered as the fold change in membrane potential
relativetosporesinthepresenceof0.1MMOPSpH6.8attheindicated
time point.
Figure 5. C-Terminal region of nisin is essential for membrane disrup-
tion. At time 0 (prior to the addition of BHI as germinant and 10 μM
nisin, c-nisin, or vancomycin) and 30 min, aliquots were removed from
the cultures and evaluated for the following: (A, C) Membrane disrup-
tion by measuring PI uptake by the entire population of B. anthracis
spores using ﬂow cytometry. (B) Population of spores that exhibited an
increase in ﬂuorescence associated with PI uptake. The data are plotted
as the percent of spores that took up PI. Data in panels A and C are
rendered as the fold change in PI uptake relative to spores in the
presence of 0.1 M MOPS pH 6.8 at the indicated time point.750 dx.doi.org/10.1021/cb1004178 |ACS Chem. Biol. 2011, 6, 744–752
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Modification of the Nisin Hinge Region Results in Loss of
Outgrowth Inhibition. Previous studies have reported conflict-
ing results as to whether Dha5 is essential for outgrowth
inhibition.
8,10,20,38 Therefore, experiments were conducted to
determine the necessity of Dha5 for membrane disruption
resulting in outgrowth inhibition. Nisin and nisin-Dha5Ala were
heterologously produced in E. coli
30 (h-nisin and h-nisinS5A,
respectively). Both compounds inhibited membrane potential
establishment and spore outgrowth and increased PI uptake
(Figure 6, Supplementary Table S3) to the same extent. These
results show that Dha5 is not essential for spore outgrowth
inhibition, as reported previously by Moll and co-workers,
38 and
that the mutation does not change the mechanism of inhibition.
A second region of interest for mutation is the hinge region
betweenthethreeN-terminalringsandthetwoC-terminalrings.
The double mutants N20P/M21P and M21P/K22P retain lipid
II binding aﬃnity but not pore-forming activity.
5,6,39 These
mutants were prepared in this study by heterologous expression
in E. coli (h-nisin N20P/M21P and h-nisin M21P/K22P) and
analyzed for their ability to disrupt the spore membrane and
inhibit membrane potential establishment and spore outgrowth.
As depicted in Figure 6, both mutants lost these activities (see also
SupplementaryTableS5).Importantly,IC99experimentsagainst
M. ﬂavus indicated that the heterologously expressed nisin
variants have the same biological activities as those puriﬁed from
L. lactis
6 and that these variants have high activity against vegeta-
tive cells of B. anthracis Sterne 7702 (Supplementary Table S6) .
These data corroborate the ﬁndings with the truncated analogue
c-nisinanddemonstratethattheabilitytoformporesinthespore
membrane isessentialfor outgrowthinhibition. Inaddition, they
show that membrane disruption is not essential for inhibiting
growth of vegetative cells but is essential for inhibiting spore
outgrowth.
Conclusions.Previous work implicatednisin-mediatedaltera-
tions in the membrane integrity and prevention of the establish-
ment of a membrane potential as the mechanism by which nisin
inhibits spore outgrowth.
8 10,26 Whether or not interactions
with lipid II were important for these activities was not deter-
mined. Utilizing fluorescently labeled nisin and vancomycin,
competition experiments, and nisin analogues, lipid II was
identified in this study as the target for nisin to induce inhibition
of spore outgrowth. Lipid II binding alone is not sufficient for
Figure 6. A ﬂexible hinge region, not Dha5, is essential for preventing establishment of a membrane potential, inhibition of spore outgrowth, and
membrane disruption. At time 0 and 30 min, aliquots were removed from the cultures and evaluated for the following: (A) Membrane potential by
measuring the ﬂuorescence of DiOC2-associated B. anthracis using ﬂow cytometry. (B) Membrane disruption by measuring PI uptake by B. anthracis
using ﬂow cytometry. (C) Population of spores exhibiting an increase in ﬂuorescence associated with PI uptake. The data are plotted as the percent of
sporesthattookupPI.(A,B)Dataarerenderedasthefoldchangeinmembranepotential(A)orPIuptake(B)relativetosporesinthepresenceof0.1M
MOPSpH6.8attheindicatedtimepoint.(D)Attime0,5,and10h,sampleswereremovedandvisualizedbyDICmicroscopy.Foreachpanel,asingle
spore is shown for clarity, but the image is representative of all other B. anthracis spores within that sample. The data are representative of those from
three independent experiments. All experiments were performed with 10 μM nisin or analogue.751 dx.doi.org/10.1021/cb1004178 |ACS Chem. Biol. 2011, 6, 744–752
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outgrowth inhibition, however, which requires membrane dis-
ruption. Modification of Dha5 to Ala does not result in the loss
of outgrowth inhibition and membrane disruption. We antici
pate that lantibiotics such as subtilin,
40,41 epidermin,
42 and
haloduracin
43 also inhibit spore outgrowth via pore formation
and that lipid II binding may also be involved in nisin inhibition
of other spore-forming bacteria from the genera Bacillus and
Clostridium,includingthoseofmedicalrelevancesuchasC.botulinum
and C. difficile.
Germinated spores no longer have antibiotic resistance asso-
ciated with spore dormancy, yet they have not yet begun
virulence factor expression. Therefore, germination is an ideal
point in the spore-forming bacterial life cycle for antibiotic
intervention to eliminate or prevent infection.
9 Current anti-
biotic treatments require that the endospore be fully converted
into a vegetative cell with a functional metabolism as current
antibioticstargetproteinsynthesis,cellwallbiosynthesis,speciﬁc
metabolic pathways, or DNA replication. Cell wall biosynthesis
and DNA replication inhibition will prevent bacteremia by
preventing growth, but drugs targeting these processes will not
eliminate the eﬀects of bacterial toxins on the host. Therefore,
ribosomal inhibitors are required in conjunction with growth-
inhibiting antimicrobials to prevent toxin synthesis to eliminate
toxemia.
44,45 The unique ability of nisin to inhibit spore out-
growth prior to toxin production
9 suggests that nisin and other
membrane-targeting antimicrobials may have potential for the
treatment of infections by spore-forming pathogens.
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